Rentomojo to file DRHP by mid-2025; posts strong performance in FY24

Furniture and appliance rental platform Rentomojo plans to file its draft red herring prospectus (DRHP) with Sebi by mid-2025, founder Geetansh Bamania said. The company is evaluating the size and timeline of the proposed IPO, a process expected to take several months.

Rentomojo reported a sharp turnaround in FY24, with profits rising to Rs 22.1 crore from Rs 6.2 crore in FY23 and revenue jumping 59% to Rs 195.8 crore. Bamania credited the success to operational efficiency and technology adoption, with 70-75% of customer queries now receiving automated approvals compared to 30% earlier.

The company expects 40% revenue growth in FY25 and aims to double profits. “We anticipate closing FY25 with an Ebitda of Rs 100 crore and profits of Rs 40 crore,” Bamania said.

Rentomojo’s revenue is evenly split between furniture and appliance rentals, with an 85% inventory occupancy rate and gross margins exceeding 60%. Operating 20 warehouses nationwide, the company partners with third-party logistics for deliveries and offers free relocation services.

The platform’s subscription model addresses a gap in affordability, Bamania explained. “Furnishing a 1BHK costs around Rs 2 lakh, which is five to six times the average monthly salary of Rs 30,000-40,000. With frequent job changes, a subscription model offers flexibility and affordability over credit or EMI options”.

Rentomojo’s performance contrasts with competitor Furlenco, which saw losses widen to Rs 130.2 crore in FY24 while revenue declined to Rs 151.9 crore.

The company is open to pre-IPO funding, with substantial interest from investors. Existing investors, including Chiratae Ventures (22.3%), Accel (20.5%), and Bain Capital Ventures (6.8%), may participate further. Rentomojo has raised $93.2 million to date, with its latest funding round in February 2024 valuing it at $110 million, down from $198 million in 2021.

 » Read More

Related Articles

How will markets open today? Here are top 7 cues to watch ahead of trading on February 11

GIFT Nifty indicated that Indian equity indices BSE Sensex and NSE Nifty 50 are implied to open on a higher note on Tuesday. Also, Asian markets opened majorly on a higher note in early trade hours as investors looked past the tariff threats from Donald Trump. Previously, on Monday, the NSE Nifty 50 finished the

Stocks To Watch: Reliance Ind, Grasim Ind, Bata, Titan, ONGC, IHCL, Nykaa, Lupin, Eicher Motors, Ahoka Buildcon

GIFT Nifty indicated that Indian equity indices BSE Sensex and NSE Nifty 50 may see a higher opening on Tuesday. Here’s a look at the key stocks to watch in trade. Stocks in Focus: Here’s a comprehensive list of stocks to keep in mind before you start your day. From Reliance Industries to Ashoka Buildcon

DIIs place big bets on 2 pharma giants. Multibaggers in the making?

By Suhel Khan As the world’s largest supplier of generic drugs, renowned for its cost-effective vaccines and generic medicines, India plays a very important role in global medicine. The Indian pharmaceutical industry has transformed into a flourishing sector, currently ranking third globally in terms of production volume and 14th in terms of value. Over the

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

How will markets open today? Here are top 7 cues to watch ahead of trading on February 11

GIFT Nifty indicated that Indian equity indices BSE Sensex and NSE Nifty 50 are implied to open on a higher note on Tuesday. Also, Asian markets opened majorly on a higher note in early trade hours as investors looked past the tariff threats from Donald Trump. Previously, on Monday, the NSE Nifty 50 finished the

Stocks To Watch: Reliance Ind, Grasim Ind, Bata, Titan, ONGC, IHCL, Nykaa, Lupin, Eicher Motors, Ahoka Buildcon

GIFT Nifty indicated that Indian equity indices BSE Sensex and NSE Nifty 50 may see a higher opening on Tuesday. Here’s a look at the key stocks to watch in trade. Stocks in Focus: Here’s a comprehensive list of stocks to keep in mind before you start your day. From Reliance Industries to Ashoka Buildcon

DIIs place big bets on 2 pharma giants. Multibaggers in the making?

By Suhel Khan As the world’s largest supplier of generic drugs, renowned for its cost-effective vaccines and generic medicines, India plays a very important role in global medicine. The Indian pharmaceutical industry has transformed into a flourishing sector, currently ranking third globally in terms of production volume and 14th in terms of value. Over the

Rupee fall hurts India Inc hard

The rupee inched closer to the 88-mark against the US dollar on Monday, putting companies in import-sensitive sectors on the edge. While firms fear a surge in imported inflation on account of rupee depreciation, consumer electronics companies, for instance, are taking price hikes to protect margins. In sectors such as thermal power, where the cost

Bata India Q3 profit grows marginally to Rs 58.6 crore on weak demand

Footwear major Bata India on Monday reported a marginal 1% growth in its net profit at Rs 58.6 crore during the October-December quarter, as compared to Rs 57.9 crore in the same quarter in 2023-24. Bloomberg consensus estimates had pegged the net profit during the quarter at Rs 72 crore.  The company’s revenue from operations